300238 冠昊生物
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资16,825-0.59%16,92517,40659,06366,595
投资性房地产8,792-2.46%9,014000
固定资产157,389-2.82%161,958182,734199,940218,401
在建工程100,48835.81%73,9912,8022,4122,232
无形资产73,882-6.07%78,66087,49264,14473,992
商誉0--00214,330214,330
其他非流动资产72,1391.94%70,76880,950123,435121,145
429,5154.42%411,317371,383663,323696,694

流动资产
货币资金109,7404.38%105,136126,280159,308156,202
应收账款60,854-0.47%61,14371,976106,706116,350
存货70,836-1.07%71,60161,677140,548126,900
其他流动资产23,802-19.04%29,39838,95628,85138,582
265,232-0.77%267,278298,889435,414438,034

流动负债
短期借款22,516-8.17%24,51949,04851,564102,877
应付票据0--0000
应付帐款8,633-70.56%29,3232,1641,8813,006
其他流动负债117,309-1.32%118,874137,777208,826196,820
148,458-14.05%172,716188,989262,270302,703
流动资产净值116,77423.49%94,562109,900173,144135,331
资产总额减流动负债546,2897.99%505,879481,284836,467832,025

非流动负债
长期借款46,052283.29%12,0150054,600
应付债券0--0000
其他非流动负债34,339-8.68%37,60350,34088,30560,765
80,39262.02%49,61850,34088,305115,365

总权益
    实收股本265,1560.00%265,156265,156265,156265,156
    储备项目273,6367.12%255,438220,188518,765465,112
股东权益538,7923.50%520,594485,344783,921730,268
非控股权益(72,895)13.31%(64,334)(54,400)(35,759)(13,608)